Filtered By:
Condition: Patent Foramen Ovale
Procedure: Cardiac Catheterization

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 19 results found since Jan 2013.

Routine troponin measurements are unnecessary in acute ischemic stroke evaluations (P4.285)
CONCLUSIONS: Troponin elevation in patients with ischemic stroke is not caused by acute myocardial ischemia unless iatrogenic in the setting of vasopressor administration. Serum troponins should be measured based on clinical context rather than routinely in all acute ischemic stroke patients.Disclosure: Dr. Ali has nothing to disclose. Dr. Young has nothing to disclose. Dr. Rabinstein has received royalty payments from Elsevier and Oxford University Press. Dr. Rabinstein has received research support from DJO Global. Dr. Flemming has nothing to disclose. Dr. Fugate has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Ali, F., Young, J., Rabinstein, A., Flemming, K., Fugate, J. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Ischemic Stroke Care Source Type: research

Sensitivity of transcranial doppler and transoesophageal echocardiography for the detection of patent foramen ovale in cryptogenic stroke
Conclusions TCD with bubble test is sensitive and specific for the detection of right–to–left shunts due to PFO confirmed at right heart catheterisation. In this population, TOE had low sensitivity for RLS. There was no difference in physical PFO size between TOE positive and negative patients.
Source: Journal of Neurology, Neurosurgery and Psychiatry - October 9, 2013 Category: Neurosurgery Authors: Morhij, D., Dani, K., Stewart Hillis, W., Muir, K. Tags: Headache (including migraine), Neuroimaging, Stroke, Hypertension, Ischaemic heart disease, Radiology, Radiology (diagnostics) Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23-24 October 2013 Source Type: research

Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long‐term follow‐up of 301 cases
Patent foramen ovale has been identified as a conduit for paradoxical embolism resulting in cryptogenic stroke or transient ischemic attack (TIA). We aimed to establish rates of death, recurrent stroke or TIA among patients undergoing PFO closure for stroke or TIA at our unit. A retrospective analysis of all PFO closure patients was performed between May 2004 and January 2013. Follow up was performed by mortality tracing using the Medical Research Information Service of the Office of National Statistics. With regard to stroke or TIA recurrence, written consent forms and questionnaires were mailed with follow up telephone c...
Source: Catheterization and Cardiovascular Interventions - June 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Mikaeil Mirzaali, Maureen Dooley, Dylan Wynne, Nina Cooter, Lorraine Lee, Peter Haworth, Romi Saha, Nicola Gainsborough, David Hildick‐Smith Tags: Valvular and Structural Heart Diseases Source Type: research

Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data
ConclusionsBased on the results of this analysis of randomized trial data, percutaneous PFO closure appears to be a safe and effective therapeutic option for the secondary prevention of ischemic stroke in patients with PFO and cryptogenic stroke.
Source: Catheterization and Cardiovascular Interventions - January 14, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Abdul Hakeem, Mehmet Cilingiroglu, Angelos Katramados, Konstantinos Dean Boudoulas, Cezar Iliescu, Betul Gundogdu, Konstantinos Marmagkiolis Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Management of patients with patent foramen ovale and cryptogenic stroke
Conclusions: Available data provided the basis for a shared approach to management of cryptogenic ischemic cerebral events and PFO among different Italian scientific societies. Wider international initiatives on the topic are awaited. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - June 21, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Christian Pristipino, Gian Paolo Anzola, Luigi Ballerini, Antonio Bartorelli, Moreno Cecconi, Massimo Chessa, Andrea Donti, Achille Gaspardone, Giuseppe Neri, Eustaquio Onorato, Gualtiero Palareti, Serena Rakar, Gianluca Rigatelli, Gennaro Santoro, Danilo Tags: Pediatric and Congenital Heart Disease Source Type: research

Initial experience with the novel patent foramen ovale occlusion device Nit‐Occlud® in patients with stroke or transient ischemic attack
ConclusionIn patients with cryptogenic stroke or TIA and a PFO, the Nit‐Occlud® PFO Occlusion Device appears to be both a safe and effective means to occlude the PFO. It is associated with high procedural success and favorable rates of complete closure. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - April 2, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Daniel H. Steinberg, Stefan C. Bertog, Julia Momberger, Jennifer Franke, Ilona Hofmann, Kristina Renkhoff, Sonya Joy, Laura Vaskelyte, Horst Sievert Tags: Valvular and Structural Heart Diseases Source Type: research

Searching for patent foramen ovale in a 44-year-old female patient after ischemic stroke - diagnostic problems.
We present the case of a 44-year-old female patient after ischemic stroke, in whom PFO was not detected by echocardiography; the defect was ultimately diagnosed by right heart catheterization. PMID: 27516797 [PubMed]
Source: Polish Journal of Cardio-Thoracic Surgery - August 16, 2016 Category: Cardiovascular & Thoracic Surgery Tags: Kardiochir Torakochirurgia Pol Source Type: research

Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta ‐analysis?
Key Points Closure of patent foramen ovale (PFO) in embolic stroke of undetermined source (ESUS) reduces recurrent stroke compared with antiplatelet therapy in select patients but increases risk of atrial fibrillation. Device closure is an attractive option for young patients with an anatomically higher risk PFO and imaging proven ESUS. Benefit of PFO closure in ESUS compared with oral anticoagulation remains undefined.
Source: Catheterization and Cardiovascular Interventions - November 26, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Arka Chatterjee, William B. Hillegass Tags: Valvular and Structural Heart Diseases Source Type: research

Long‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Long ‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient ‐years of follow up
ConclusionThe Occlutech device appears to be safe at long ‐term FU with a very low annual cerebrovascular event rate and a low moderate to large shunt rate at 1‐year FU.
Source: Catheterization and Cardiovascular Interventions - November 20, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Roel J. R. Snijder, Laura E. Renes, Maarten Jan Suttorp, Jurrien M. ten Berg, Martijn C. Post Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Interventional closure of patent foramen ovale with Nit ‐occlud® device in prevention of recurrent neurologic events—Long‐term results
ConclusionsThe Nit‐Occlud PFO device and its delivery system are safe and provides sufficient closure of PFO in patients who suffered from cryptogenic stroke, TIA or paradoxical peripheral embolism. It is associated with high procedural success and favorable rates of complete closure.
Source: Catheterization and Cardiovascular Interventions - October 25, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Aleksander Araszkiewicz, Sylwia S ławek, Olga Trojnarska, Maciej Lesiak, Marek Grygier Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Results of percutaneous closure of patent foramen ovale with the GORE® septal occluder
ConclusionPFO closure with the GSO is accompanied by a high technical success rate and closure rates similar to other currently used devices. The incidence of AF was higher than reported with most other devices. This may be a chance finding but warrants further investigation in larger trials. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - January 20, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Meike Knerr, Stefan Bertog, Laura Vaskelyte, Ilona Hofmann, Horst Sievert Tags: Valvular and Structural Heart Diseases Source Type: research

HeartStitch touts new PFO closure method
Structural heart focused HeartStitch said today its NobleStitch EL device was used to repair 3 patients with patent forman ovale heart defects in Astana, Kazakhstan. A patent foramen ovale is a congenital heart disease in which hole in the heart that normally seals at birth remains open, and can lead to severe migraines, visual auras and stroke, the company said. The procedures were performed by Dr. Michael Mullen and guided by Anthony Nobles at the National Research Cardiac Surgery Center in Astana, according to the company. “We are gratified that our colleagues from abroad have brought this technology to Kazakhstan...
Source: Mass Device - September 11, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular HeartStitch Source Type: news

Amplatzer left atrial appendage occlusion: Single center 10‐year experience
ConclusionLAA closure may be a good alternative to oral anticoagulation. This hypothesis needs to be tested in a randomized clinical trial to ensure that all potential biases of this observational study are accounted for. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 14, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Fabian Nietlispach, Steffen Gloekler, René Krause, Samera Shakir, Michael Schmid, Ahmed A. Khattab, Peter Wenaweser, Stephan Windecker, Bernhard Meier Tags: Original Studies Source Type: research